Core Viewpoint - Iovance Biotherapeutics Inc. is undergoing a leadership transition with the resignation of CFO Jean-Marc Bellemin amid commercial challenges and a class-action lawsuit related to its flagship drug Amtagvi [1][2][3]. Group 1: Leadership Transition - CFO Jean-Marc Bellemin will resign effective July 10, 2025, to pursue other endeavors, having held the position since November 2020 [1][2]. - The company has not yet named a successor for the CFO role, creating uncertainty during a challenging period [2]. Group 2: Commercial Challenges - Iovance's first-quarter sales for Amtagvi significantly underperformed expectations, leading to a downward revision of full-year revenue projections [3]. - The company's stock price fell over 44%, from $3.17 on May 8, 2025, to $1.75 by the close of trading on May 9, 2025, reflecting investor concerns about commercial execution [7]. Group 3: Legal Issues - Iovance is facing a class-action lawsuit alleging securities fraud related to the company's portrayal of its authorized treatment centers (ATCs) and their role in driving demand for Amtagvi [4][5]. - The lawsuit claims that ATCs experienced delays in initiating treatments and inefficiencies in patient selection, leading to higher patient drop-off rates [5][6]. - Hagens Berman is investigating the allegations to determine if the company's public statements were consistent with internal realities [8].

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between April 29, 2025, and June 23, 2025 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Hims was involved in the deceptive promotion and sale of illegitimate versions of Wegovy®, which posed risks to patient safety [2] - It is alleged that this situation created a substantial risk of termination of Hims' collaboration with Novo Nordisk [2] - The defendants' positive statements regarding the Company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 25, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4]

Core Viewpoint - Rocket Pharmaceuticals, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to the safety and clinical trial protocol of its RP-A501 treatment, which resulted in a significant stock price decline after the FDA placed a clinical hold on the study [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by alleged securities fraud between February 27, 2025, and May 26, 2025 [1]. - Defendants allegedly provided misleading statements about the safety of RP-A501 while concealing serious adverse events, including participant deaths during the clinical trial [2]. - Following the announcement of the FDA's clinical hold on May 27, 2025, Rocket's stock price plummeted from $6.27 to $2.33 per share, a decline of approximately 37% in one trading day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until August 11, 2025, to request appointment as lead plaintiff, although participation does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the United States [4].

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reddit, Inc. ("Reddit, Inc." or the "Company") (NYSE: RDDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reddit, Inc. investors who were adversely affected by alleged securities fraud between October 29, 2024 and May 20, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/reddit-inc-lawsuit-submis ...

Core Viewpoint - A class action securities lawsuit has been filed against Krispy Kreme, alleging securities fraud that negatively impacted investors between March 26, 2024, and May 7, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Krispy Kreme's management made overly positive statements while concealing adverse facts about the demand for its products at McDonald's locations [2] - It is alleged that lower demand at McDonald's led to declining average weekly sales per store, and the partnership with McDonald's was not profitable, causing Krispy Kreme to pause expansion plans [2] - Krispy Kreme reported a net revenue decline of $404 million, or 10.4%, and a decrease in average sales per store due to changing customer preferences [2] Group 2: Stock Price Impact - Following the release of disappointing financial results on February 25, 2025, Krispy Kreme's stock price fell from $9.13 to $7.13 per share [2] - On May 8, 2025, the company announced a first-quarter 2025 net revenue of $375.2 million, a decline of 15.3% or $67.5 million, leading to a further stock price drop from $4.33 to $3.26 per share, a decrease of about 25% in one day [2] Group 3: Next Steps for Investors - Investors who suffered losses during the relevant period have until July 15, 2025, to request to be appointed as lead plaintiff in the lawsuit [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 4: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - A class action securities lawsuit has been filed against Compass Group Diversified Holdings, LLC due to alleged securities fraud affecting investors between February 24, 2022, and May 7, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Compass Diversified failed to disclose effective internal controls over financial reporting and critical information regarding its subsidiary, Lugano Holding, Inc., which had undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [2]. - The truth about these issues emerged on May 7, 2025, when Compass announced that its financial statements for fiscal 2024 could no longer be relied upon due to an internal investigation into Lugano, leading to a significant drop in stock price from $17.25 to $6.55 per share [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until July 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Bitfarms Ltd. alleging securities fraud that affected investors between March 21, 2023, and December 9, 2024 [1][2]. Group 1: Allegations and Financial Misstatements - The lawsuit claims that Bitfarms had inadequate internal controls over financial reporting [2]. - It is alleged that the company misclassified proceeds from the sale of digital assets, categorizing them as cash flow from operating activities instead of investing activities [2]. - The complaint states that Bitfarms overstated its ability to remediate material weaknesses in its internal controls related to the classification of the 2021 Warrants [2]. - These errors led to misstatements in several previously issued financial statements, which are now deemed inaccurate and likely to require restatement [2]. - As a result, the company's public statements were materially false and misleading during the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Bitfarms Ltd. during the specified timeframe have until July 8, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - Petco Health and Wellness Company, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between January 14, 2021, and June 5, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Petco's pandemic-related business advantages were not sustainable and that its business model, which focuses on premium pet food, was overstated [2] - It is alleged that the defendants downplayed the severity of issues affecting Petco's business and the necessary changes to address these issues, which could negatively impact comparable sales [2] - The lawsuit asserts that the defendants misrepresented Petco's ability to achieve sustainable and profitable growth, leading to materially false and misleading public statements [2] Group 2: Next Steps for Investors - Investors who suffered losses in Petco during the specified timeframe have until August 29, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant compensation for shareholders and has extensive experience in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - Investors in Reddit, Inc. (NYSE: RDDT) have the opportunity to lead a securities fraud class action lawsuit due to undisclosed material information affecting the company's performance [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from October 29, 2024, to May 20, 2025, Reddit's management failed to disclose significant changes in Google Search's algorithm that negatively impacted user traffic to Reddit [2]. - Key allegations include that the changes in Google's algorithm led to a decrease in users' queries on Reddit, which was materially different from previous traffic reductions [2]. - It is claimed that the increase in searches for "Reddit" was due to users finding answers directly on Google, rather than intending to visit Reddit, leading to a dramatic reduction in traffic that the company could not mitigate in the short term [2]. - The lawsuit asserts that the defendants lacked a reasonable basis for their forecasts regarding user rates and advertising revenues, making their positive statements about the company's business misleading [2]. Participation Information - Investors who suffered losses related to Reddit are encouraged to participate in the class action lawsuit before the lead plaintiff deadline of August 18, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the lawsuit [3][4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea Holdings Inc. due to allegations of misleading statements and financial misrepresentations that have led to significant investor losses [2][4]. Group 1: Legal Investigation and Claims - Investors who suffered losses exceeding $50,000 in Fortrea between July 3, 2023, and February 28, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - A federal securities class action has been filed against Fortrea, with an August 1, 2025, deadline for investors to seek the role of lead plaintiff [2]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea overestimated revenue contributions from Pre-Spin Projects and overstated cost savings from exiting Transition Services Agreements (TSAs), leading to inflated EBITDA targets for 2025 [4]. - The company's public statements regarding its business model and financial prospects were deemed materially false and misleading [4]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in its business model and a stock price drop of $2.73 per share (12.29%) [5]. - Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, after the company canceled two scheduled conferences, resulting in a stock price decline of $1.90 per share (8.06%) [6]. - Following the announcement of disappointing financial results on March 3, 2025, Fortrea's stock price fell by $3.47 per share (25.05%) [7].